What is Cefuroxime Sodium Inj. 250 Mg750mg/1500mg?

Cefuroxime Sodium Injection is a cephalosporin antibiotic containing cefuroxime sodium as its active ingredient. Cefuroxime is a second-generation cephalosporin used to manage certain bacterial infections when clinically appropriate. Presented as a dry powder injection, the product requires preparation and administration according to its approved product information by qualified healthcare professionals.

Uses / Indications

Cefuroxime is used to treat certain bacterial infections caused by susceptible organisms. Depending on the approved product information and local treatment guidelines, its clinical uses may include:

• Selected respiratory tract infections.

• Certain urinary tract infections.

• Skin and soft-tissue infections caused by susceptible bacteria.

• Selected bone and joint infections.

• Other susceptible bacterial infections where cefuroxime is an appropriate treatment.

• Surgical infection prevention in specific clinical settings, where indicated by the relevant product information.

The approved indications for this specific presentation must be confirmed against its prescribing information and the regulatory requirements of the intended market. It is not intended for treating viral infections such as influenza or the common cold.

6. Benefits

• Contains cefuroxime sodium, an established cephalosporin antibacterial active ingredient.

• Dry powder injection presentation for preparation according to approved product instructions.

• May be used in appropriate clinical settings for infections caused by susceptible bacteria.

• Vial presentation suitable for professional healthcare use, subject to confirmation of the specific product specifications.

• Pharmaceutical sourcing and export enquiries can be directed to Kelar Pharmachem India.

These characteristics do not imply guaranteed treatment outcomes or superiority over alternative antibiotics.

7. Side Effects

The adverse effects below are associated with cefuroxime injection generally. The exact incidence and product-specific warnings should be checked against the applicable package insert.

Common Side Effects

• Injection-site discomfort or inflammation.

• Diarrhoea.

• Nausea.

• Skin rash.

Less Common or Serious Side Effects

• Severe allergic reactions, including anaphylaxis.

• Severe or persistent diarrhoea associated with antibiotic treatment, including Clostridioides difficile-associated colitis.

• Kidney-related adverse effects, particularly in patients with relevant risk factors.

• Blood-related abnormalities.

• Neurological reactions, including seizures in susceptible patients, particularly where renal impairment and inappropriate dosing are involved.

Seek prompt medical assessment if a serious reaction is suspected. Emergency treatment is required for signs of a severe allergic reaction, such as difficulty breathing or swelling of the face or throat.

8. How Does It Work?

Cefuroxime belongs to the beta-lactam group of antibiotics. It works by binding to bacterial penicillin-binding proteins and interfering with the formation of the bacterial cell wall. This weakens the cell wall and can lead to bacterial cell death in susceptible organisms. Its activity depends on the organism’s susceptibility, and it is not effective against viral infections.

9. Dosage Guidelines

The dosage of Cefuroxime Sodium Injection must be determined by a qualified healthcare professional according to:

• The type and severity of the infection.

• The susceptibility of the causative organism.

• The patient’s age, weight and clinical condition.

• Renal function and any necessary dose adjustment.

• The strength and approved instructions for the specific product.

The strengths supplied are recorded as 250 Mg750mg/1500mg and have not been reinterpreted as separate presentations. The appropriate dose and available vial strengths must be confirmed before prescribing.

Dry powder injections must be prepared and administered by qualified healthcare professionals according to the approved product instructions. Reconstitution volumes, diluents, administration routes and treatment duration must not be assumed from the product name alone.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

10. When Not to Use

Cefuroxime Sodium Injection should not be used in patients with a known contraindicating hypersensitivity to cefuroxime or the cephalosporin group, as specified in the applicable product information.

Before treatment:

• Review any history of allergic reactions to cephalosporins, penicillins or other beta-lactam antibiotics.

• Assess previous severe drug allergies carefully.

• Confirm the patient’s clinical suitability with a qualified healthcare professional.

A history of penicillin allergy does not automatically establish the same level of risk for every cephalosporin. The type and severity of the previous reaction must be assessed before use.

11. Drug / Product Interactions

Clinically relevant considerations for cefuroxime injection may include:

• Aminoglycoside antibiotics: Concurrent treatment may increase the risk of kidney toxicity.

• Potent diuretics: Particular caution may be required because of potential renal risks.

• Anticoagulants: Monitoring of coagulation parameters may be appropriate in patients at risk of altered prothrombin activity.

• Laboratory tests: Cefuroxime may affect certain urine glucose and blood glucose testing methods.

The relevance of each interaction depends on the patient’s treatment and the applicable prescribing information. Healthcare professionals should review concurrent medicines and relevant laboratory monitoring requirements.

12. Safety Advice

• Use only when prescribed or authorised by an appropriately qualified healthcare professional.

• Review the patient’s allergy history before administration.

• Confirm the correct product, strength and intended route.

• Follow approved preparation and administration instructions.

• Assess renal function when clinically indicated.

• Monitor for significant adverse reactions, including allergic reactions and severe diarrhoea.

• Use antibiotics only for appropriate bacterial indications to support antimicrobial stewardship.

• Assess pregnancy, breastfeeding and paediatric use according to the relevant prescribing information.

13. General Instructions

• Verify the product name, strength, batch number and expiry date before use.

• Check the vial and container closure for damage or other visible concerns.

• Follow the product-specific instructions for reconstitution and administration.

• Use appropriate aseptic handling practices.

• Do not use a product that fails applicable quality checks.

• Observe the approved conditions for use after reconstitution.

• Dispose of unused medicine, sharps and clinical waste according to applicable procedures.

Do not use a general preparation method in place of the instructions for the specific product.

14. Special Dietary / Lifestyle Tips

No universal dietary restriction is established for all patients receiving cefuroxime sodium injection. Dietary and lifestyle advice should be based on the patient’s clinical condition and professional guidance.

• Follow the prescribed treatment schedule.

• Complete treatment as directed by the treating healthcare professional.

• Do not share antibiotics with other people.

• Report persistent diarrhoea or other significant adverse symptoms promptly.

• Avoid using leftover antibiotics without medical assessment.

15. Comparison with Other Treatments

Cefuroxime Sodium Injection belongs to the second-generation cephalosporin group. Its clinical role differs from those of other cephalosporins and other antibacterial classes.

Other antibiotics may be more appropriate for particular organisms or infection sites. Selection should be guided by clinical assessment, culture and susceptibility results where available, and local treatment guidelines. This comparison does not establish superiority over alternative treatments.

16. Precautions & Warnings

• Hypersensitivity: Serious allergic reactions can occur. Review the patient’s allergy history before treatment.

• Renal impairment: Dose adjustment may be necessary when kidney function is reduced.

• Gastrointestinal complications: Persistent or severe diarrhoea during or after treatment requires medical evaluation.

• Neurological risks: Patients with renal impairment may be at increased risk of adverse neurological effects if exposure becomes excessive.

• Concurrent medicines: Assess medicines that may affect renal function or coagulation.

• Antimicrobial resistance: Unnecessary or inappropriate use can contribute to antibiotic resistance.

• Special populations: Pregnancy, breastfeeding, paediatric use and treatment in older adults should be assessed using the applicable prescribing information.

These precautions are based on established cefuroxime injection information; the final product listing should be checked against the specific manufacturer’s approved label.

17. Can I Use It With Other Medicines?

Cefuroxime Sodium Injection may be administered alongside other medicines only when the combination is considered appropriate by a qualified healthcare professional.

Inform the treating healthcare professional about all prescription medicines, non-prescription medicines and relevant supplements being used.

Two separate issues must be assessed:

• Drug interactions: Whether the medicines affect each other’s safety or clinical management.

• Physical compatibility: Whether medicines can safely be mixed in the same syringe, infusion or administration line.

Do not mix cefuroxime with another medicine unless compatibility has been confirmed using reliable product-specific information.

18. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage conditions before reconstitution and the permitted handling period after reconstitution must be confirmed from the specific product documentation. No storage temperature or post-reconstitution shelf life has been assumed for this listing.

19. Frequently Asked Questions (FAQs)

1. What is Cefuroxime Sodium Injection used for?

It is an injectable cephalosporin antibiotic used for selected bacterial infections caused by susceptible organisms, subject to the product’s approved indications.

2. Which active ingredient does this product contain?

The stated active ingredient is cefuroxime sodium.

3. What strengths are available?

The supplied strength wording is 250 Mg750mg/1500mg. The individual strengths and their presentation should be confirmed with the approved product specification.

4. How is this dry powder injection prepared?

It must be prepared by a qualified healthcare professional according to the approved product-specific instructions. The diluent, reconstitution volume and administration procedure have not been specified here.

5. Can patients with a penicillin allergy use cefuroxime?

A history of penicillin allergy requires assessment before treatment. The nature and severity of the reaction and the patient’s clinical circumstances should be reviewed by a qualified healthcare professional.

6. What precautions are required before administration?

Confirm the patient’s allergy history, prescribed strength, intended route and relevant clinical factors, including renal function where appropriate. Follow the approved instructions.

7. How should Cefuroxime Sodium Injection be stored?

Follow the manufacturer’s approved labelling and the instructions supplied with the specific product. Storage conditions after reconstitution must also be verified.

8. Is this product available for pharmaceutical export?

Kelar Pharmachem India is a pharmaceutical sourcing and export company. Product availability, supply arrangements, documentation and destination-market requirements should be confirmed directly with the company.